These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9633594)
21. Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids. Berton A; Rigot V; Huet E; Decarme M; Eeckhout Y; Patthy L; Godeau G; Hornebeck W; Bellon G; Emonard H J Biol Chem; 2001 Jun; 276(23):20458-65. PubMed ID: 11278959 [TBL] [Abstract][Full Text] [Related]
22. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components. Wallon UM; Overall CM J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449 [TBL] [Abstract][Full Text] [Related]
23. Collagen-binding domain of human plasma fibronectin contains a latent type-IV collagenase. Lambert Vidmar S; Lottspeich F; Emod I; Imhoff JM; Keil-Dlouha V Eur J Biochem; 1991 Oct; 201(1):79-84. PubMed ID: 1655429 [TBL] [Abstract][Full Text] [Related]
24. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly. Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093 [TBL] [Abstract][Full Text] [Related]
25. Molecular properties of wild-type and mutant betaIG-H3 proteins. Kim JE; Park RW; Choi JY; Bae YC; Kim KS; Joo CK; Kim IS Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):656-61. PubMed ID: 11867580 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains. Gioia M; Monaco S; Fasciglione GF; Coletti A; Modesti A; Marini S; Coletta M J Mol Biol; 2007 May; 368(4):1101-13. PubMed ID: 17379243 [TBL] [Abstract][Full Text] [Related]
27. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280 [TBL] [Abstract][Full Text] [Related]
28. Enzymic characterization with progress curve analysis of a collagen peptidase from an enthomopathogenic bacterium, Photorhabdus luminescens. Marokházi J; Kóczán G; Hudecz F; Gráf L; Fodor A; Venekei I Biochem J; 2004 May; 379(Pt 3):633-40. PubMed ID: 14744262 [TBL] [Abstract][Full Text] [Related]
29. The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains. Wermter C; Höwel M; Hintze V; Bombosch B; Aufenvenne K; Yiallouros I; Stöcker W Biol Chem; 2007 May; 388(5):513-21. PubMed ID: 17516847 [TBL] [Abstract][Full Text] [Related]
30. Cloning, expression, purification, and characterization of rat MMP-12. Fu JY; Lyga A; Shi H; Blue ML; Dixon B; Chen D Protein Expr Purif; 2001 Mar; 21(2):268-74. PubMed ID: 11237688 [TBL] [Abstract][Full Text] [Related]
31. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
32. Identification of the active site of gelatinase B as the structural element sufficient for converting a protein to a metalloprotease. Kaur K; Zhu K; Whittemore MS; Petersen RL; Lichte A; Tschesche H; Pourmotabbed T Biochemistry; 2002 Apr; 41(15):4789-97. PubMed ID: 11939773 [TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule. O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063 [TBL] [Abstract][Full Text] [Related]
34. The proteolytic activity of the recombinant cryptic human fibronectin type IV collagenase from E. coli expression. Schnepel J; Tschesche H J Protein Chem; 2000 Nov; 19(8):685-92. PubMed ID: 11307953 [TBL] [Abstract][Full Text] [Related]
35. Degradation of the COL1 domain of type XIV collagen by 92-kDa gelatinase. Sires UI; Dublet B; Aubert-Foucher E; van der Rest M; Welgus HG J Biol Chem; 1995 Jan; 270(3):1062-7. PubMed ID: 7836360 [TBL] [Abstract][Full Text] [Related]
36. Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. St-Pierre Y; Desrosiers M; Tremblay P; Estève PO; Opdenakker G Cytometry; 1996 Dec; 25(4):374-80. PubMed ID: 8946145 [TBL] [Abstract][Full Text] [Related]
37. Unexpected crucial role of residue 272 in substrate specificity of fibroblast collagenase. Tsukada H; Pourmotabbed T J Biol Chem; 2002 Jul; 277(30):27378-84. PubMed ID: 12011042 [TBL] [Abstract][Full Text] [Related]
38. The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. Steffensen B; Bigg HF; Overall CM J Biol Chem; 1998 Aug; 273(32):20622-8. PubMed ID: 9685420 [TBL] [Abstract][Full Text] [Related]
39. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. Patterson ML; Atkinson SJ; Knäuper V; Murphy G FEBS Lett; 2001 Aug; 503(2-3):158-62. PubMed ID: 11513874 [TBL] [Abstract][Full Text] [Related]
40. Expression of collagenase/gelatinase activity from basement-membrane fibronectin--isolation after limited proteolysis of a bovine lens capsule and molecular definition of this thiol-dependent zinc metalloproteinase. Boudjennah L; Dalet-Fumeron V; Pagano M Eur J Biochem; 1998 Jul; 255(1):246-54. PubMed ID: 9692925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]